Clinical Trials on CAR-T Retreatment in United Kingdom
Total 5662 results
-
King's College Hospital NHS TrustCompletedHTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)United Kingdom
-
University of BirminghamPfizer; BloodwiseCompletedT-Cell Lymphoma Relapsed | T-Cell Lymphoma RefractoryUnited Kingdom
-
Royal Marsden NHS Foundation TrustCancer Research UKUnknownAngioimmunoblastic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Negative | Peripheral T-cell Lymphoma NOS | Hepatosplenic Gamma/ Delta T-cell LymphomaUnited Kingdom
-
Codiak BioSciencesTerminatedCutaneous T-cell Lymphoma (CTCL)United Kingdom
-
4SC AGCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T Cell LymphomaUnited Kingdom
-
Innate PharmaCompletedCutaneous T-Cell LymphomaUnited States, France, Netherlands, United Kingdom
-
Manchester University NHS Foundation TrustUniversity of Manchester; The Christie NHS Foundation Trust; Zenzium AI Ltd.; Aptus... and other collaboratorsRecruitingColorectal Cancer | Lung Cancer | Hematological Cancer | CAR T-Cell TherapyUnited Kingdom
-
Autolus LimitedRecruitingAnaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | T Cell Non-Hodgkin Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedUnited Kingdom, Spain
-
University of BirminghamCelgene; Amgen; BloodwiseCompletedPeripheral T Cell LymphomaUnited Kingdom
-
GenmabCompletedCutaneous T-Cell LymphomaUnited Kingdom, Germany, United States, Sweden
-
Cancer Research UKUnknownLymphoma | Small Intestine CancerUnited Kingdom
-
AstraZenecaCompletedSafety,Plasma AUC and Cmax, Plasma AUC 0-t, t1/2λz, and TmaxUnited Kingdom
-
University College, LondonCompleted
-
Autolus LimitedEnrolling by invitationMultiple Myeloma | DLBCL | T Cell Lymphoma | Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy | ALL, Adult and PediatricUnited Kingdom
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of ManchesterUnknownTreatment of Visual VertigoUnited Kingdom
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
European Organisation for Research and Treatment...RecruitingStage IB-IIB Cutaneous T-Cell LymphomaSpain, United Kingdom, Denmark, Italy, France, Germany, Greece
-
Kyowa Kirin, Inc.Active, not recruitingCutaneous T-Cell Lymphoma Refractory | Cutaneous T-Cell Lymphoma, RelapsedUnited States, United Kingdom, Spain, France, Italy
-
University College, LondonMerck Sharp & Dohme LLCActive, not recruitingCutaneous T Cell Lymphoma | Mycosis Fungoides/Sezary SyndromeUnited Kingdom
-
Guy's and St Thomas' NHS Foundation TrustUnknown
-
Janssen Research & Development, LLCCompletedLymphoma, T-Cell, CutaneousFrance, United Kingdom, Spain, Portugal, United States, Germany
-
Cerina TherapeuticsUniversity of Ulster; European CommissionRecruitingTreatment Adherence | Treatment Adherence and Compliance | Generalized AnxietyUnited Kingdom
-
Poole Hospital NHS Foundation TrustCompletedHemolysis | Troponin TUnited Kingdom
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive SchizophreniaUnited Kingdom
-
Cancer Research UKUnknownLymphoma | Small Intestine CancerUnited Kingdom
-
Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaFrance, United Kingdom, Netherlands, Denmark, Italy, Spain
-
Mundipharma Research LimitedInnovative Therapies For Children with Cancer ConsortiumTerminatedRelapsed or Refractory T-cell Acute Lymphoblastic Leukaemia | B-cell Precursor Acute Lymphoblastic Leukaemia | T-cell Non-Hodgkin's LymphomaCzech Republic, Austria, France, Germany, Italy, United Kingdom
-
Imperial College LondonWithdrawnAllogeneic Stem Cell Transplantation | CMV Reactivation | Autologous CMV Specific CD8+ T CellsUnited Kingdom
-
Massachusetts General HospitalActive, not recruitingHematologic Malignancy | CAR-T Cell TherapyUnited States
-
Barts & The London NHS TrustEast Kent Hospitals University NHS Foundation Trust; Southend NHS Foundation...Completed
-
Amrit SinhaNational Health Service, United KingdomUnknownTreatment as Usual | Psychological InterventionUnited Kingdom
-
Nottinghamshire Healthcare NHS TrustUniversity of Nottingham; University of Southampton; University of Leicester; Institute...TerminatedTreatment as Usual | Employment, SupportedUnited Kingdom
-
The Lymphoma Academic Research OrganisationCelgeneActive, not recruitingRelapsed Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-cell LymphomaFrance, Denmark, United Kingdom, Austria, Belgium
-
University of Alabama at BirminghamTerminatedAnaplastic Large Cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Peripheral T-cell Lymphomas | Adult T-cell Leukemia | Adult T-cell Lymphoma | Peripheral T-cell Lymphoma Unspecified | T/Null Cell Systemic Type | Cutaneous t-Cell Lymphoma With Nodal/Visceral DiseaseUnited States
-
Beckley Psytech LimitedRecruitingTreatment Resistant DepressionUnited Kingdom
-
University of BristolNorth Bristol NHS TrustCompletedMental DisordersUnited Kingdom
-
North Bristol NHS TrustUniversity of BristolUnknownTreatment Resistant DepressionUnited Kingdom
-
Weill Medical College of Cornell UniversityCompletedCardiac Surgery Intensive Care TreatmentUnited States
-
King's College LondonSouth London and Maudsley NHS Foundation TrustRecruitingTreatment Resistant DepressionUnited Kingdom
-
Kyowa Kirin, Inc.CompletedAdult T-cell Leukemia-LymphomaUnited States, United Kingdom, Belgium, France, Brazil, Peru
-
Royal Marsden NHS Foundation TrustAstraZeneca; Cancer Research UK; RM/ICR Biomedical Research CentreActive, not recruitingSolid Tumour Refractory to Conventional TreatmentUnited Kingdom
-
National Cancer Institute (NCI)WithdrawnHepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Adult T-cell Leukemia/Lymphoma | Extranodal NK-/T-cell Lymphoma, Nasal Type | Monomorphic Epiteliotrophic Intestinal T-cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedPeripheral T-Cell Lymphoma (PTCL) | T-Cell Prolymphocytic Leukemia | Cutaneous T Cell Lymphoma (CTCL) | T-Cell Lymphoma Relapsed | Adult T-Cell Leukemia (ATL)United States
-
AbbVieCompletedLeukemia | Cancer | T-cell Prolymphocytic Leukemia (T-PLL)United States, Australia, Austria, Finland, France, Germany, Italy, Netherlands, United Kingdom
-
University of OxfordCompletedTreatment Resistant Depression | Depression, UnipolarUnited Kingdom
-
Dartmouth-Hitchcock Medical CenterCompletedLymphoma | Leukemia | Multiple Myeloma | Stem Cell Transplant | Hematopoietic Stem Cell Transplant | CAR T-Cell Therapy | HSCT | Cellular Therapy | CAR T-Cell TransplantUnited States
-
University of OxfordRecruitingDepression | Major Depressive Disorder | Treatment Resistant DepressionUnited Kingdom
-
University of OxfordMedical Research Council; Johnson & Johnson Pharmaceutical Research & Development...RecruitingDepression | Major Depressive Disorder | Treatment Resistant DepressionUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterCelgene CorporationRecruitingCutaneous T-cell Lymphoma | Peripheral T-Cell Lymphoma | T-Prolymphocytic Leukemia | T-Large Granulocytic Leukemia | T-Lymphoblastic Leukemia/LymphomaUnited States